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The microinjection method used for the ¢rst time in
this study makes it possible to measure in vivo the en-
dothelium-dependent vasomotion in the nailfold capil-
laries of systemic scleroderma patients. Aceylcholine
(blood concentration of 105 M) and sodium nitroprus-
side (blood concentration of 1.6 lg per kg per min)
were used as test substances to examine capillary vaso-
motion. De¢ned quantities of medication in the range
of microliters were administered as a bolus using the
Panomat V-3 medicine pump.The boluses were injected
into the capillaries at the capillary loop in 10 scleroder-
ma patients and 10 randomized healthy volunteers.
Blood £ow velocity and the diameter of the skin capil-
laries at the venous loop were measured and tested for
correlation with the e¡ects of injections of test sub-
stances.The intracapillary administration of sodium ni-
troprusside brought about a signi¢cant decrease in
capillary blood £ow velocity and a signi¢cant increase
in vascular diameter in comparison with baseline
values, both in systemic scleroderma patients (po0.005
and po0.0001) and in the healthy volunteers (po0.001
and po0.0001). The intracapillary administration of
acetylcholine led to a signi¢cant decrease in blood £ow
velocity (po0.001) and increase in vascular diameter
(po0.0001) only in the healthy volunteers. In systemic
sclerosis patients capillary diameter and blood £ow ve-
locity were una¡ected. In two systemic scleroderma pa-
tients this procedure was repeated in identical fashion at
the end of a 1 wk infusion therapy cycle with prostacy-
clin. The infusion therapy led to a normalization of
endothelium-dependent vasomotion in the two sclero-
derma patients. The microinjection technique used in
this study for the ¢rst time made it possible to establish
in vivo that endothelium-dependent vasomotion is
disturbed in systemic scleroderma patients. Key words:
cutaneous microcirculation/microinjection/scleroderma/vasomotion.
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S
ystemic scleroderma (SSc) is a multiorgan disease charac-
terized from the onset by cutaneous microangiopathy in
the form of aneurysms, capillary rarefaction and micro-
thromboses, and the development of megacapillaries
(Maricq et al, 1980). Other morphologic changes
observed with the disease include vascular obliteration and exces-
sive collagen production in the pericapillary area (LeRoy, 1996).
The capillaries of the skin not only undergo morphologic
changes, but also display functional de¢cits. Both blood £ow ve-
locity and capillary pressure in the nailfold capillaries of SSc
patients were signi¢cantly lower than in healthy volunteers
(Hahn et al, 1998). Cold exposure leads to a marked slowing of
blood £ow velocity in the capillaries of the patients, in extreme
cases to the point of stasis (Hahn et al, 1995). In advanced cases,
vasculopathy leads to acral necroses that heal poorly and are
largely unresponsive to treatment.
In this study, endothelial function, a factor in the regulation
of perfusion, was examined in detail in SSc patients and healthy
volunteers by administering intracapillary microinjections of
vasoactive substances and monitoring the resulting endothe-
lium-dependent (acetylcholine) or endothelium-independent
(sodium nitroprusside) vasodilatation, increase in vascular dia-
meter, and decrease in blood £ow velocity.
MATERIALS ANDMETHODS
Subjects Ten healthy volunteers and 10 SSc patients were enrolled in the
study. The diagnosis of SSc in the patients participating in the study was
based on clinical symptoms, serologic markers (three female patients with
autoantibodies against topoisomerase I and nine female patients with
antibodies against kinetochore), and the typical capillaroscopic ¢ndings at
the nailfold (scleroderma-like pattern).
For any kind of microvascular study it is essential that the subjects be
relaxed and in a balanced metabolic state. The duration of the ‘‘wash-out’’
period was 7 d. During this period the patients were not allowed to take
vasoactive medication, ¢brolytics, or anticoagulants of any kind. Co¡ee,
tea, and nicotine were not to be consumed on the day of examination.
The control group was randomized with respect to age and sex. This
study was approved by the Institutional Ethics Committee. Written
informed consent was obtained from all participants.
Experimental protocol The examinations were carried out in a
climate-controlled room (23.51C70.51C) after an acclimatization phase of
30 min in a reclining position. A Leica light microscope was available for
optimal visualization of the capillaries (lens L25/0.22 PUT; Leitz,Wetzlar,
Germany). The capillaroscopic image was viewed on a compact black and
white monitor (AVT Horn, Aalen, Germany) and recorded on videotape
for later analysis (U-matic SP, Sony,Tokyo, Japan).
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Microinjection technique The test substances used to examine
capillary vasomotion were acetylcholine at a blood concentration of 105
M and sodium nitroprusside at a blood concentration of 1.6 mg per kg per
min. In healthy persons these concentrations led to an interruption of
capillary blood £ow (Schlez et al, 2000). A bolus precise in the microliter
range was injected into the capillary at the arterial-venous loop of
morphologically normal capillaries (Fig 1) using a Panomat V-3
medication pump (Disetronic, Sulzbach, Germany). Before cannulation of
the capillaries, it is often necessary to remove the keratinous layer o¡ the
skin by careful preparation with a scalpel blade. As this procedure is
painless no local anesthesia was used.
Changes in endothelial vasomotion were detected by analyzing vascular
diameter and blood £ow velocity at the venous capillary loop close to the
injection site before and after the administration of medication using a
special video image analysis system over a period of 10 s (Cap-Image,
Ingenieurbˇro Dr Zeintl, Heidelberg, Germany). The microinjection
technique requires a great deal of experience on the part of the operator.
Even then, two or three attempts were usually necessary to insert the ¢rst
micropipette. After successful insertion the experiments normally lasted
10 min.
In two SSc patients this procedure was repeated in identical fashion at
the end of an infusion therapy cycle (1 wk and 3 wk) with prostacyclin
(0.5 ng per kg per min administered over a period of 6 h per d).
Statistical analysis The di¡erences in the response of blood £ow
velocity and vascular diameter after the intracapillary administration of
acetylcholine and sodium nitroprusside between healthy subjects and SSc
patients were tested for signi¢cance with a two-sided paired Student’s t test
(signi¢cance level o0.05). The plots show the medians and their 95%
con¢dence intervals.
RESULTS
Acetylcholine injected into the capillaries at a blood
concentration of 105 M has a di¡erent e¡ect on blood £ow
velocity and the diameter of the venous capillary loop in
SSc patients than it does in healthy controls In the healthy
volunteers acetylcholine caused a signi¢cant decrease in blood
£ow velocity (median 0.84 mm per s, SD 0.4 vs median 0.4 mm
per s, SD 0.3; po0.001), but not in the SSc patients (median 1.25
mm per s, SD 0.7 vs median 1.15 mm per s, SD 0.7) (Fig 2).
Venous capillary diameter increased signi¢cantly in the healthy
controls after the administration of acetylcholine (median 7.4
mm, SD 3.8 vs median 12.9 mm, SD 4.7; po0.0001), but it did
not do so in SSc patients (median 28.4 mm, SD 9.7 vs median
29.2 mm, SD 10.3) (Fig 3).
Sodium nitroprusside at a blood concentration of 1.6 lm per
kg per min caused a signi¢cant change in capillary blood
£ow velocity both in the patients and in the healthy
controls. Blood £ow velocity dropped from median 1.1 mm
per s (SD 0.6) to 0.27 mm per s (SD 0.3; po0.005) in the patients
and from median 0.81 mm per s (SD 0.7) to 0.22 mm per s (SD
0.3; po0.001) in the healthy controls (Fig 1). Venous capillary
nail
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Figure1. Illustration of the cannulation procedure on nailfold ca-
pillaries with a glass pipette.
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Figure 2. Capillary blood £ow velocity (mm per s) before and after
administration of acetylcholine (blood concentration 105 M) (A)
and sodium nitroprusside (blood concentration 1.6 lg per kg per
min) (B) in patients (right) and in healthy controls (left).
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Figure 3. Capillary diameter (lm) before and after administration
of acetylcholine (blood concentration 105 M) (A) and sodium
nitroprusside (blood concentration 1.6 lg per kg per min) (B) in
patients (right) and healthy controls (left).
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diameter increased signi¢cantly both in healthy controls (median
9.0 mm, SD 2.3^13.7 mm, SD 3.2; po0.0001) and in the SSc
patients (median 22.0 mm, SD 10.2^29 mm, SD 11.7; po0.0001)
after the administration of sodium nitroprusside (Fig 3).
One week of infusion therapy with prostacyclin led to a
normalization of endothelium-dependent vasomotion in two of
the scleroderma patients. After the injection of acetylcholine,
capillary blood £ow velocity slowed from 0.34 mm per s to 0.12
mm per s or 0.41 mm per s to 0 mm per s and capillary diameter
increased from 30.1 mm to 37.3 mm or 16.6 mm to 19.4 mm.
DISCUSSION
An intact, functional endothelium is a prerequisite for the regula-
tion of microcirculatory blood £ow. Acetylcholine causes en-
dothelium-dependent vasodilatation at the endothelium of
isolated arteries. If the endothelium is damaged, e.g. by essential
hypertension or cardiomyopathia or following sepsis, the vasodi-
lative e¡ect of acetylcholine is absent (Panza et al, 1990; Treasure
et al, 1995;Wang et al, 1995).
Unlike the patients with SSc, the healthy controls in this study
reacted with endothelium-dependent vasodilatation after the in-
tracapillary administration of acetylcholine, as evident in an in-
crease in venous capillary diameter and a decrease in blood £ow
velocity. At the larger arteries, the vasodilative e¡ect of acetylcho-
line was primarily caused by an increased release of the endothe-
lium-derived relaxing factor (Furchgott and Zawadzki, 1980).The
mechanism behind acetylcholine-induced vasodilatation in hu-
man cutaneous blood vessels has less to do with NO-mediated
relaxation than with the increased release of prostacyclin stored
in the endothelium (Warren, 1994; Noon et al, 1998). This me-
chanism is absent when the endothelium is damaged. The
normalization of endothelium-dependent vasomotion after
prostacyclin infusions supports the hypothesis that a functional
disorder of the endothelium is responsible for the absence of
prostacyclin release. This putative pathomechanism remains to
be tested in studies on a larger patient pool.
L-Arginine is the substrate for NO synthesis by vascular en-
dothelial cells. Khan and Belch (1999) could show that the lack
of e¡ect of supplementation with L-arginine suggests that the ab-
normality of endothelial-dependent vasodilatation in the digital
vasculature of patients with SSc may be independent of the L-ar-
ginine/NO pathway. So the e¡ector mechanism for NO is intact.
If the endothelial cells of the postcapillary venules are distended,
this can cause a contraction of precapillary sphincters upstream,
which is also governed by endothelial mediators, neuro-
genous factors, the veno-arteriole axon re£ex, etc. (Henriksen,
1977). Thus, blood £ow velocity at the capillary loop must slow
when the postcapillary endothelial cells of the venules are dis-
tended, as we were able to show in the healthy volunteers in our
study. In scleroderma patients acetylcholine, the test substance
used to investigate endothelium-dependent vasomotion, causes
neither a signi¢cant decrease in capillary blood £ow velocity nor
an increase in vascular diameter, in contrast to what we observed
in healthy controls.We interpreted this as evidence of endothelial
damage in the SSc patients.
Intimal damage to the blood vessels of SSc patients has already
been demonstrated serologically in studies showing elevated le-
vels of antibleeding factor, endothelin-1, and ACE (Gordon and
Madhok, 1996; Herrick et al, 1996; Maeda et al, 1997). The trigger
for the endothelial damage is still unknown. One potential cause
presently under discussion is a vasculopathy caused by cytomega-
lovirus or parvovirus B19 (Ferri et al, 1999). Recently, it was pos-
sible to show that autoantibodies to human cytomegalovirus
cause the apoptosis of endothelial cells in SSc patients (Lunardi
et al, 2000).
Because its mode of action is independent of the endothelium,
sodium nitroprusside exerts a vasodilative e¡ect both on sclero-
derma patients and on healthy persons. In other words, the capil-
lary diameter increased signi¢cantly in both groups and capillary
blood £ow velocity decreased after administration. Sodium ni-
troprusside activates the guanylate cyclase of the smooth muscle
cells in the blood vessels, causing endothelium-independent vas-
cular dilatation. In the capillaries, which have no muscular vascu-
lar layer, another mechanism must be at work behind the
vasodilative e¡ect observed at the venous loop in both groups.
In animal models it was possible to show that sodium nitroprus-
side causes dilatation of the precapillaries at the microcirculatory
level, as well as a reduction of nutritive perfusion resulting from
the re-routing of blood through arterio-venous shunts. This
could explain the slowing of blood £ow velocity that has been
observed (Franke et al, 1981).
The microinjection method used for the ¢rst time in this study
made it possible to establish that endothelium-independent vaso-
motion is substantially disturbed in patients with scleroderma.
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